Wang, H., Yu, C., Gao, X., Welte, T., Muscarella, A.M., Zhao, H., Zhao, Z., Tao, J., Lee, B., Westbrook, T.F., Wong, S.T.C., Jin, X., Rosen, J.M., Osborne, C.K., Zhang, X.H.F. (2015) The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells. Cancer Cell 27(2):193-210. PMID: 25600338.
Hsu, T.Y-T., Simon, L.M., Neill, N., Marcotte, R., Sayad, A., Bland, C.S., Sun, T., Dominguez-Vidaña, R., Kurley, S.J., Tyagi, S., Karlin, K.L., Hartman, J.D., Renwick, A., Bernardi, R.J., Skinner, S.O., Jain, A., Orellana, M., Lagisetti, C., Golding, I., Jung, S.Y., Neilson, J.R., Zhang, X., Webb, T.R., Neel, B.G., Shaw, C.A., Westbrook, T.F., (2015) The spliceosome is a therapeutic vulnerability in Myc-driven cancer. Nature. 525(7569): 384-388. PMID: 26331541.
- Commentary: Stine, Z.E, Dang, C.V. (2015) Splicing and dicing MYC-mediated synthetic lethality. Cancer Cell. 28(4): 405-406.
- Commentary: Alderton, G. (2015) YC: splicing up your survival. Nature Reviews Cancer. 15(10): 574-574.
- Commentary: Poh, A. (2015) A vulnerable side to MYC-driven cancers. Cancer Discovery. Epub ahead of print.
- Commentary: Poh, A. (2015) Anczukow, O., Krainer, A.R. (2015) The spliceosome, a potential Achilles heel of MYC-driven cancers. Genome Medicine. 7(1): 107.
Mahamdallie, S.S., Hanks, S., Karlin, K.L., Zachariou, A., Perdeaux, E., Ruark, E., Shaw, C.A., Renwick, A., Ramsay, E., Yost, S., Elliott, A., Birch, J., Capra, M., Gray, J., Hale, J., Kingston, J., Levitt, G., McLean, T., Sheridan, E., Renwick, A., Seal, S., Stiller, C., Sebire, N., Westbrook, T.F., Rahman, N., (2015) Mutations in the transcriptional repressor REST predispose to Wilms tumor. Nature Genetics 47(12): 1471-1474.
Welte, T., Zheng, D., Kim, I.S., Tian, L, Gao, X., Wang, H., Li, J., Holdman, X.B., Herschkowitz, J.I., Pond, A., Pang, L., Liao, L., Huang, S., Xu, J., Li, Y., Lewis, M.T., Wang, T., Westbrook, T.F., Rosen, J.M., Zhang, X.H.F., Oncogenic mTOR signaling promotes myeloid-derived suppressor cell accumulation and links tumor-initiating capacity to immunosuppression. Nature Cell Biology (in press).
Karlin, K.L., Mondal, G., Hartman, J.K., Nair, A., Tyagi, S., Kurley, S.J., Bland, S.J., Hsu, T.Y-T., Renwick, A., Fang, J.E., Migliaccio, I., Callaway, C., Dominguez-Vidana, R., Nguyen, D.X., Osborne, C.K., Schiff, R., Gutierrez, C., Jung, S.Y., Edwards, D., Hilsenbeck, S.G., Zhang, X., Shaw, C.A., Couch, F.J., Westbrook, T.F., (2014) The oncogenic STP axis promotes human breast cancer via degradation of the REST tumor suppressor. Cell Reports. 9(4): 1318-1332.
Miao,Q., Ku,A., Nishino,Y., Howard,J.M., Rao,A.S., Shaver,T.M., Garcia,G.E., Le,D., Karlin, K.L, Westbrook, T.F., Poli, V., Nguyen, H. (2014) Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. Nature Communications, 5:4088-96. PMID: 24909826.
Terunuma, A., Putluri, N., Mishra, P., Mathe, E.A., Dorsey, T.H., Yi, M., Wallace, T.A., Issaq, H.J., Zhou, M., Killian, J.K., Stevenson, H.S., Karoly, E.D., Chan, K., Samanta, S., Edelman, D.C., Wulff, J., Starks, A.M., Yang, Y., Kittles, R.A., Yfantis, H.G., Lee, D.H., Ioffe, O.B., Schiff, R., Stephens, R.M., Meltzer, P.S., Veenstra, T.D., Westbrook, T.F., Sreekumar,A., and Ambs, S. (2014) MYC-driven 2-hydroxyglutarate is associated with breast cancer prognosis. Journal of Clinical Investigation, 124(1): 398-412.
Villegas, E., Kabotyanski, E.B., Montemayor, C., Herschkowitz, J.I., Shore, A.N., Creighton, C.J., Shaw, C.A., Westbrook, T.F., Rosen, J.M. (2014) Plk2 regulates mitotic spindle orientation and mammary gland development. Development, 141(7): 1562-1571.
Pavolova, N., Pallasch, C., Elia, A., Westbrook, T.F., Hemann, M., Elledge, S.J. (2013) A Role for PVRL4-driven Cell-Cell Interactions in Tumorigenesis. eLife.
Park, J., Al-Ramahi, I., Mollema, N., Kang, H., Lagalwar, S., Duvick, L., Lee, Y., Tan, Q., Lu, H-C., Jafar-Nejad, P., Richman, R., Liu, X., Boudreau, R.L., Davidson, B.L, Shaw, C.A., Orr, H.T.*, Westbrook, T.F.*, Botas, J.*, Zoghbi, H.Y.* (2013) Cross-species genetic screen reveals a role for Ras/MAPK in the neurodegenerative disorder Spinocerebellar Ataxia Type 1 (SCA1). Nature, 498(7454): 325-331.
- *co-corresponding
- Commentary: Ferrarelli, L.K. (2013) Conserved signals in neurodegeneration. Science Signaling. 6 (281): 143.
- Commentary: Gregg, C. (2013) Modifying Genetic Disease. Science Translational Medicine. 192: 143.
Cheung, W.K.C., Zhao, M., Liu, Z., Stevens, L.E. Cao, P.D., Fang, J., Westbrook, T.F., Nguyen, D.X. (2013) Control of Alveolar Differentiation by the Lineage Transcription Factors GATA6 and HOPX Inhibits Lung Adenocarcinoma Metastasis. Cancer Cell, 23(6): 725-738. PMID: 23707782.
- Commentary: Watanabe, H. and Meyerson, M. (2013) Hopping between Differentiation States in Lung Adenocarcinoma. Cancer Cell, 23 (6): 707-709.
Pei, Y., Moore, C.E., Wang, J., Tewari, A.K., Eroshkin, A., Cho, Y.J., Witt, H., Korshunov, A., Read, T., Sun, J.L., Schmitt, E.M., Miller, C.R., Buckley, A.F., McLendon, R.E., Westbrook, T.F., Northcott, P.A., Taylor, M.D., Pfister, S.M., Febbo, P.G., Wechsler-Reya, R.J. (2012) An animal model of Myc-driven medulloblastoma. Cancer Cell, 21(2):155-67. PMID: 22340590.
- Commentary: Eberhart, C.G. (2012) Three Down and One to Go: Modeling Medulloblastoma Subgroups, Cancer Cell, 21(2): 137.
Kessler, J.D., Kahle, K.T., Sun, T., Meerbrey, K.L., Schlabach, M.R., Schmitt, E.M., Skinner, S.O., Xu, Q., Li, M.Z., Hartman, Z.C., Rao, M., Yu, P., Dominguez-Vidana,R., Liang, A.C., Solimini, N.L, Bernardi, R.J., Yu, B., Hsu, T., Golding, I., Luo, J., Osborne, C.K., Creighton, C.J., Hilsenbeck, S.G., Schiff, R., Shaw, C.A., Elledge, S.J., Westbrook, T.F. A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science, 335(6066): 348-53. PMID: 22157079
- Commentary: Evan, G. (2012) Cancer: taking a back door to target Myc, Science, 335(6066):293-4.
Sun, T., Aceto, N., Meerbrey, K.L., Kessler, J.D., Zhou, C., Migliaccio, I., Nguyen, D.X., Pavlova, N.N., Botero, M., Huang, J., Bernardi, R.J., Schmitt, E.M., Hu, G., Li, M.Z., Dephoure, N., Rao, M., Gygi, S.P., Creighton, C.J., Hilsenbeck, S.G., Shaw, C.A., Muzny, D., Gibbs, R., Wheeler, D., Osborne, C.K., Schiff, R., Bentires-Alj, M., Elledge, S.J., Westbrook, T.F. (2011) Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase, Cell, 144(5):703-18. PMID: 21376233.
- Commentary: Albeck, J.G., Brugge, J.S. (2011) Uncovering a tumor suppressor for triple-negative breast cancers, Cell, 144(5): 638-40.
- Commentary: M. Landis. (2011). PTPN12 loss is oncogenic in triple-negative breast cancer, Cancer Discovery (inaugural issue), 1(1): 11.
Meerbrey, K.L., Hu, G., Kessler, J.D., Roarty, K., Li, M.Z., Fang, J.E., Herschkowitz, J.I., Burrows, A.E., Ciccia, A., Sun, T., Schmitt, E.M., Bernardi, R.J., Fu, X., Bland, C.S., Cooper, T.A., Schiff, R., Rosen, J.M., Westbrook, T.F.*, Elledge, S.J.* (2011) The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo, PNAS, 108(9): 3665-70. PMID: 21307310.
- *co-corresponding, co-equal contribution
Luo, J., Emanuele, M.J., Li, D., Schlabach, M.R., Creighton, C., Westbrook, T.F., Wong, K., Elledge, S.J. (2009) A genome-wide synthetic lethal RNAi screen identifies multiple genetic dependencies of the Ras oncogene, Cell, 137(5): 835-48. PMID: 19490893.
- Commentary: Seton-Rogers, S. (2009) Therapeutics: Dependent on KRAS, Nature Reviews Cancer, 9:457.
Mulligan, P. Westbrook, T.F., Wiedemeyer, R.M., Chin, L., Elledge, S.J, Shi, Y. (2008) CDYL Bridges REST and histone methyltransferases for gene repression and suppression of cell transformation, Molecular Cell, 32(5): 718-26. PMID: 19061646.
- Commentary: McCarthy, N. (2009) Oncogene repression: CDYL and REST – a silent team, Nature Reviews Cancer, 9: 80.
Schlabach, M.R., Luo, J., Hu, G., Solimini, N.L., Xu, Q., Li, M.Z., Zhao, Z., Smogorzewska, A., Sowa, M.E., Ang, X.L., Westbrook, T.F., Liang, A.C., Chang, K., Hackett, J.A., Harper, J.W., Hannon, G.J., Elledge, S.J. (2008) Cancer Proliferation Gene Discovery Through Functional Genomics, Science, 319(5863): 620-624.* PMID: 18239126.
- Commentary: Hayden, E.C.(2008) ‘Normal’ genes key to cancer growth. Nature, 451(7179): 615.
Westbrook, T.F., Hu, G., Ang, X.L., Mulligan, P., Liang, A., Leng, Y., Shi, Y., Harper, J.W., Elledge, S.J. (2008) SCFbTRCP Controls Oncogenic Transformation and Neural Differentiation Through REST Degradation, Nature, 452(7185):370-374. PMID: 18354483.
- Commentary: Weissman, A.M. (2008) How much REST is enough? Cancer cell, 13(5):381-383.
- Commentary: Alderton, G.K. (2008) Signalling: An oncogene becomes RESTless. Nature Reviews Cancer, 8: 327.
Westbrook, T.F., Stegmeier, F., Elledge, S.J. (2005) Dissecting Cancer Pathways and Vulnerabilities with RNAi. LXX Cold Spring Harbor Symposium on Quantitative Biology: Molecular Approaches to Controlling Cancer. 70: 434-444. PMID: 16869781.
Westbrook, T.F., Martin, E.S., Schlabach, M.R., Leng Y., Liang, A.C., Feng, B., Zhao, J.J., Roberts, T.M., Mandel, G., Hannon, G.J., DePinho, R.A., Chin, L., Elledge, S.J. (2005) A Genetic Screen for Candidate Tumor Suppressors Identifies REST. Cell, 121(6):837-848.* PMID: 15960972.
- Commentary: Downward, J. (2005) RNA interference libraries prove their worth in hunt for tumor suppressor genes. Cell, 121(6): 813-815.-
- Commentary: Bangham, J. (2005) A Screen Success. Nature Reviews Cancer, 5: 586.
Paddison, P.J., Silva, J.M., Conklin, D.S., Schlabach, M., Li, M., Aruleba, S., Balija, V., O’Shaughnessy, A., Gnoj, L., Scobie, K., Chang, K., Westbrook, T.F., Sachidanandam, R., McCombie, W.R., Elledge, S.J., Hannon, G.J. (2004) A Resource for Large-Scale RNAi Based Screens in Mammals. Nature, 428(6981) :375-378. PMID: 15042091.
- Commentary: Fraser, A. (2004) RNA interference: Human genes hit the big screen. Nature, 428(6981): 377.